INSIGHTS ON CELL & GENE MANUFACTURING AND LOGISTICS

• Master Control Quality Excellence

  An interconnected digital platform unifies quality documents, training, and corrective actions. Learn to eliminate manual gaps and use automated metrics to drive long-term operational excellence.

• Startup Decision Guide: Right-Size Your Life Science QMS

  Evaluating quality frameworks requires balancing immediate compliance with long-term scalability. Learn to analyze organizational maturity and regulatory demands to select an optimal system.

• The Connectivity Crisis Blocking AI Deployment

  Disconnected systems and siloed data block analytics in life sciences manufacturing. Learn to bridge the infrastructure gap and build a connected foundation for scalable intelligence.

• Mapping Early-Phase Supply Chain Bottlenecks That Doom Pipelines

  Many sponsors miscast preclinical development as an unglamorous step between discovery and the clinic. Here's how the consequences may lead to irrevocable losses.

• How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale

  Our latest Cell & Gene Live examined how CGT developers can choose manufacturing models that support long-term commercial success by aligning biology, operations, supply chain, and scalability from the earliest stages of development.

• Supporting Late-Stage Drug Product Development

  Meet Coriolis Pharma at CPHI Worldwide in Milan to explore solutions for late-stage drug product development, manufacturing readiness, and CMC support.

• From LAL To rFC: The Evolution Of Endotoxin Testing

  Protect patient safety and ensure regulatory compliance by implementing sensitive, reliable bacterial endotoxin testing as a critical component of pharmaceutical quality assurance.

• Accelerate Efficiency By Decoupling Collection From Manufacturing

  Cryopreservation eliminates rigid timelines by decoupling collection from production, providing the flexibility needed to optimize facility use and stabilize advanced therapy supply chains.

• How Operational Efficiency Shapes Late-Phase Manufacturability

  Prioritize operational efficiency over early-stage flexibility to scale advanced therapies. Standardized workflows and qualified shipping lanes reduce variability for predictable late-phase success.

• The Next Cancer Revolution Isn't Science– It's Manufacturing

  Transitioning to distributed manufacturing can reduce costs, overcome infrastructure barriers, and expand access to advanced cell therapies for oncology patients worldwide.